Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value

被引:8
作者
Zhou, Jiale [1 ]
Yang, Zhaolin [1 ]
Wu, Xiaorong [1 ]
Zhang, Jin [1 ]
Zhai, Wei [1 ]
Chen, Yonghui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, 160 Pujian Rd, Shanghai 200127, Peoples R China
基金
中国国家自然科学基金;
关键词
Clear cell renal cell carcinoma (ccRCC); obesity; prognosis; biomarker; MONOAMINE-OXIDASE; CANCER; EXPRESSION; ASSOCIATION; ACTIVATION; MECHANISMS; LEPTIN; RISK; IGKC;
D O I
10.21037/tau-20-891
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: Renal cell carcinoma (RCC) is a common urologic malignancy. Although the relationship between clear cell RCC (ccRCC) and obesity has been well-established by several large-scale retrospective studies, the molecular mechanisms and genetic characteristics behind this correlation remains unclear. In the current study, several bioinformatics tools were used to identify the key genes in ccRCC related to obesity. Methods: Microarray data comparing ccRCC with normal renal tissues in patients with and without obesity were downloaded from the GEO database for screening of differentially expressed genes (DEGs). The DEGs were verified with expression level and survival analysis using several online bioinformatics tools. Results: In the current study, the differential expression of five genes correlated with both ccRCC and obesity; IGHA1 and IGKC as oncogenes, and MAOA, MUC20 and TRPM3 as tumor suppressor genes. These genes were verified by comparing the relationship between the expression levels and survival outcomes from open-source data in The Cancer Genome Atlas (TCGA) dataset. Conclusions: In conclusion, the five genes differentially expressed in ccRCC and obesity are related to disease progression and prognosis, and therefore could provide prognostic value for patients with ccRCC.
引用
收藏
页码:680 / 691
页数:12
相关论文
共 36 条
[1]   Global burden of cancer attributable to high body-mass index in 2012: a population-based study [J].
Arnold, Melina ;
Pandeya, Nirmala ;
Byrnes, Graham ;
Renehan, Andrew G. ;
Stevens, Gretchen A. ;
Ezzati, Majid ;
Ferlay, Jacques ;
Miranda, J. Jaime ;
Romieu, Isabelle ;
Dikshit, Rajesh ;
Forman, David ;
Soerjomataram, Isabelle .
LANCET ONCOLOGY, 2015, 16 (01) :36-46
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma [J].
Bex, Axel ;
Albiges, Laurence ;
Ljungberg, Borje ;
Bensalah, Karim ;
Dabestani, Saeed ;
Giles, Rachel H. ;
Hofmann, Fabian ;
Hora, Milan ;
Kuczyk, Markus A. ;
Lam, Thomas B. ;
Marconi, Lorenzo ;
Merseburger, Axel S. ;
Staehler, Michael ;
Volpe, Alessandro ;
Powles, Thomas .
EUROPEAN UROLOGY, 2017, 71 (05) :719-722
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Renal cell carcinoma [J].
Cairns, Paul .
CANCER BIOMARKERS, 2011, 9 (1-6) :461-473
[6]   Epidemiology of Renal Cell Carcinoma [J].
Capitanio, Umberto ;
Bensalah, Karim ;
Bex, Axel ;
Boorjian, Stephen A. ;
Bray, Freddie ;
Coleman, Jonathan ;
Gore, John L. ;
Sun, Maxine ;
Wood, Christopher ;
Russo, Paul .
EUROPEAN UROLOGY, 2019, 75 (01) :74-84
[7]   MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway [J].
Chen, Chi-Hau ;
Shyu, Ming-Kwang ;
Wang, Shu-Wei ;
Chou, Chih-Hsing ;
Huang, Miao-Juei ;
Lin, Tzu-Chi ;
Chen, Syue-Ting ;
Lin, Ho-Hsiung ;
Huang, Min-Chuan .
GYNECOLOGIC ONCOLOGY, 2016, 140 (01) :131-137
[8]   Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway [J].
Chen, Syue-Ting ;
Kuo, Ting-Chun ;
Liao, Ying-Yu ;
Lin, Mei-Chun ;
Tien, Yu-Wen ;
Huang, Min-Chuan .
ONCOGENE, 2018, 37 (46) :6041-6053
[9]   Obesity, Inflammation, and Cancer [J].
Deng, Tuo ;
Lyon, Christopher J. ;
Bergin, Stephen ;
Caligiuri, Michael A. ;
Hsueh, Willa A. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :421-449
[10]   Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers [J].
Denkert, Carsten ;
von Minckwitz, Gunter ;
Brase, Jan C. ;
Sinn, Bruno V. ;
Gade, Stephan ;
Kronenwett, Ralf ;
Pfitzner, Berit M. ;
Salat, Christoph ;
Loi, Sherene ;
Schmitt, Wolfgang D. ;
Schem, Christian ;
Fisch, Karin ;
Darb-Esfahani, Silvia ;
Mehta, Keyur ;
Sotiriou, Christos ;
Wienert, Stephan ;
Klare, Peter ;
Andre, Fabrice ;
Klauschen, Frederick ;
Blohmer, Jens-Uwe ;
Krappmann, Kristin ;
Schmidt, Marcus ;
Tesch, Hans ;
Kuemmel, Sherko ;
Sinn, Peter ;
Jackisch, Christian ;
Dietel, Manfred ;
Reimer, Toralf ;
Untch, Michael ;
Loibl, Sibylle .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :983-991